Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Path News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Path Today - Breaking & Trending Today

Comparing UiPath (NASDAQ:PATH) and iClick Interactive Asia Group (NASDAQ:ICLK) - Vimarsana News

Comparing UiPath (NASDAQ:PATH) and iClick Interactive Asia Group (NASDAQ:ICLK)

UiPath (NASDAQ:PATH – Get Rating) and iClick Interactive Asia Group (NASDAQ:ICLK – Get Rating) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends. Earnings and Valuation This table compares UiPath and […]

UiPath (NASDAQ:PATH) Downgraded to "Strong Sell" at Zacks Investment Research - Vimarsana News

UiPath (NASDAQ:PATH) Downgraded to "Strong Sell" at Zacks Investment Research

Zacks Investment Research cut shares of UiPath (NASDAQ:PATH – Get Rating) from a hold rating to a strong sell rating in a research note published on Thursday morning, Zacks.com reports. According to Zacks, “UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in […]

Reviewing UiPath (PATH) and Its Peers - Vimarsana News

Reviewing UiPath (PATH) and Its Peers

UiPath (NASDAQ:PATH – Get Rating) is one of 399 publicly-traded companies in the “Prepackaged software” industry, but how does it weigh in compared to its competitors? We will compare UiPath to related companies based on the strength of its earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Analyst Recommendations This is a breakdown […]

UiPath (NASDAQ:PATH) Price Target Cut to $55.00 by Analysts at Truist Financial - Vimarsana News

UiPath (NASDAQ:PATH) Price Target Cut to $55.00 by Analysts at Truist Financial

UiPath (NASDAQ:PATH – Get Rating) had its target price reduced by Truist Financial from $75.00 to $55.00 in a report released on Thursday morning, The Fly reports. Truist Financial currently has a buy rating on the healthcare company’s stock. A number of other research firms have also weighed in on PATH. Wells Fargo & Company […]

UiPath (NASDAQ:PATH) Price Target Lowered to $40.00 at Mizuho - Vimarsana News

UiPath (NASDAQ:PATH) Price Target Lowered to $40.00 at Mizuho

UiPath (NASDAQ:PATH – Get Rating) had its price objective reduced by Mizuho from $70.00 to $40.00 in a research report sent to investors on Thursday morning, The Fly reports. They currently have a buy rating on the healthcare company’s stock. Other research analysts also recently issued research reports about the company. Berenberg Bank upgraded UiPath […]